Baseline PET imaging of CD4+ and CD8a+ was conducted in the same panel of syngeneic mouse models prior to treatment with Sym021 to evaluate the predictive value of TIL imaging for treatment response across various tumor types (Figure 4A). This evidence concerns the gene CD8A and neoplasm.